Avicenna Alliance provided feedback to the public consultation on European Medicines Agencies Network Strategy to 2025


On 4 September the Avicenna Alliance provided feedback to the public consultation on European Medicines Agencies Network Strategy to 2025!

The purpose of this public consultation was to seek views from EMA’s and HMA's stakeholders, partners and the general public on the proposed joint European Medicines Agencies Network Strategy to 2025 and whether it meets stakeholders’ needs.

Avicenna Alliance Position Paper on the Pharmaceutical Strategy – Timely patient access to affordable medicines


On 15 September the Avicenna Alliance submitted Member's feedback to the survey on the pharmaceutical strategy! While providing Members' feedback to the Commission's survey on the pharmaceutical strategy, the Alliance has also joined to its response a tailored position paper which has been developed by members of the Avicenna Alliance from medtech, pharmaceutical, software and life science industries and scientific community from academia.

Avicenna Alliance Executive Summary - The role of Artificial Intelligence within in silico medicine


Members of the Avicenna Alliance were eager to provide feedback the European Commission’s White Paper on artificial intelligence and therefore started working on an Avicenna Alliance white paper on ‘’the role of artificial intelligence within in silico medicine”. Given the great interest shown by the members of the Alliance and the time necessary to respond to the European Commission's public consultation on AI, it was decided to produce a provisional executive summary on “The role of Artificial Intelligence within in silico medicine “ as an introduction to the white paper to be published later in 2020 to provide feedback to the European Commission.

Avicenna Alliance Position Paper - AI and Big Data effective readiness: A privacy-enhancing pathway to data access


The Avicenna Alliance warmly welcomes the European Commission’s ambitious policy package, including the European strategy for data and the White Paper on artificial intelligence aimed at making the EU fit for the digital age. In particular, the Avicenna Alliance Members welcome the European Commission’s Data Strategy and its various references to the promising opportunities brought by health data for personalised medicine and the benefits and advances that computer modelling and simulation technologies can bring in healthcare.

To make the best of the new EU strategy, the Members of the Avicenna Alliance have drafted this position paper which applies both to the Public Consultations on a European Strategy for Data and the White Paper on Artificial Intelligence. This document has been developed by members of the Avicenna Alliance from medtech, pharmaceutical, software and...

Avicenna Alliance Members Case Studies on in silico medicine


What can CM&S accomplish? Nothing short of redefining terms like ‘patient safety’, ‘efficacy’ and ‘cost effectiveness’ by forever raising the quality of data needed to meet high standards.

To do this we need to demonstrate what can be already done to give an idea of what we could do in future with the right regulator support and uptake across the healthcare sector.

The case studies in this document give but a glimpse of the potential that has yet to be unleashed by modelling and simulation.

Avicenna Alliance White Paper - Modelling And Simulation As A Transformative Tool for Medical Devices: The Transatlantic Regulatory Landscape


This White Paper highlights the potential of computer modelling and simulation in medtech and the regulatory and political barriers to unlocking that full potential.

Developed by Members of the Avicenna Alliance from the Medtech and Software sectors as well as the FDA, this paper is the starting point for a much needed discussion on how the policy framework governing the healthcare sector can be reformed to adapt to the technologies of the digital age that can in turn be put to use to solve some of the greatest healthcare challenges facing society.

This paper was official launched in the European Parliament on 04 September 2018 and is addressed to policy makers and regulators familiar with existing EU regulatory structures as well as those experienced in the medtech or software spheres.

Avicenna Alliance news

WHO issues first global report on use of AI in healthcare

Artificial Intelligence (AI) applications in health innovation are rapidly increasing, reflecting the potential of these technologies to...

find out more ›

Slovenian Presidency of the Council of the EU launches its six-month programme!

On 1 July, for the second time since joining the EU in 2004, Slovenia has taken over the Presidency of the Council of...

find out more ›

Members of the European Parliament call EU Health Commissioner to place in silico medicine on her policy agenda from 2021 onwards!

On 22 June, a group of five Members of the European Parliament...

find out more ›

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up